X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PFIZER TTK HEALTHCARE/
PFIZER
 
P/E (TTM) x 18.4 34.4 53.6% View Chart
P/BV x 2.2 5.4 39.9% View Chart
Dividend Yield % 0.8 0.6 122.5%  

Financials

 TTK HEALTHCARE   PFIZER
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
PFIZER
Mar-18
TTK HEALTHCARE/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,4582,365 61.6%   
Low Rs7951,625 48.9%   
Sales per share (Unadj.) Rs408.7430.3 95.0%  
Earnings per share (Unadj.) Rs12.978.7 16.3%  
Cash flow per share (Unadj.) Rs23.693.2 25.4%  
Dividends per share (Unadj.) Rs5.0020.00 25.0%  
Dividend yield (eoy) %0.41.0 44.3%  
Book value per share (Unadj.) Rs164.9586.5 28.1%  
Shares outstanding (eoy) m14.1345.75 30.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.84.6 59.4%   
Avg P/E ratio x87.625.3 345.6%  
P/CF ratio (eoy) x47.621.4 222.5%  
Price / Book Value ratio x6.83.4 200.8%  
Dividend payout %38.925.4 153.0%   
Avg Mkt Cap Rs m15,91691,271 17.4%   
No. of employees `0002.22.6 85.3%   
Total wages/salary Rs m1,0903,143 34.7%   
Avg. sales/employee Rs Th2,573.87,484.8 34.4%   
Avg. wages/employee Rs Th485.71,195.0 40.6%   
Avg. net profit/employee Rs Th81.01,369.1 5.9%   
INCOME DATA
Net Sales Rs m5,77619,685 29.3%  
Other income Rs m761,143 6.6%   
Total revenues Rs m5,85120,828 28.1%   
Gross profit Rs m4265,003 8.5%  
Depreciation Rs m152663 23.0%   
Interest Rs m474 1,126.2%   
Profit before tax Rs m3025,479 5.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1201,878 6.4%   
Profit after tax Rs m1823,601 5.0%  
Gross profit margin %7.425.4 29.0%  
Effective tax rate %39.734.3 115.9%   
Net profit margin %3.118.3 17.2%  
BALANCE SHEET DATA
Current assets Rs m2,55624,167 10.6%   
Current liabilities Rs m1,6759,544 17.6%   
Net working cap to sales %15.374.3 20.5%  
Current ratio x1.52.5 60.3%  
Inventory Days Days3355 60.7%  
Debtors Days Days3529 121.8%  
Net fixed assets Rs m1,1039,514 11.6%   
Share capital Rs m141458 30.9%   
"Free" reserves Rs m2,18826,375 8.3%   
Net worth Rs m2,33026,832 8.7%   
Long term debt Rs m725 26.4%   
Total assets Rs m4,07336,900 11.0%  
Interest coverage x7.41,305.5 0.6%   
Debt to equity ratio x00 304.1%  
Sales to assets ratio x1.40.5 265.8%   
Return on assets %5.69.8 57.6%  
Return on equity %7.813.4 58.1%  
Return on capital %14.920.4 73.1%  
Exports to sales %3.00-   
Imports to sales %0.60-   
Exports (fob) Rs m172NA-   
Imports (cif) Rs m35NA-   
Fx inflow Rs m17222 767.9%   
Fx outflow Rs m551,489 3.7%   
Net fx Rs m117-1,466 -8.0%   
CASH FLOW
From Operations Rs m2533,318 7.6%  
From Investments Rs m-226-2,383 9.5%  
From Financial Activity Rs m-72-1,104 6.5%  
Net Cashflow Rs m-41-169 24.5%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 3.7 7.5 49.3%  
FIIs % 5.2 4.9 106.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 23.7 108.9%  
Shareholders   12,723 85,207 14.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   WYETH LTD  IPCA LABS  NATCO PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; DHFL Down Over 9%(12:30 pm)

Share markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the realty sector, capital goods sector.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 22, 2019 02:25 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS